Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism - PubMed (original) (raw)
Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism
D Jallut et al. Metabolism. 1990 Oct.
Abstract
To investigate the time course of glucose metabolism in obesity 33 patients (21 to 69 years old; body mass index [BMI], 25.7 to 53.3 kg/m2) with different degrees of glucose intolerance or diabetes who had been studied initially and 6 years later were submitted to the same 100-g oral glucose tolerance test (OGTT) with indirect calorimetry. From a group of 13 obese subjects with normal glucose tolerance (NGT), four developed impaired glucose tolerance (IGT); from a group of nine patients with IGT, three developed non-insulin-dependent diabetes mellitus (NIDDM); five of six obese NIDDM subjects with high insulin response developed NIDDM with low insulin response. Five patients had diabetes with hypoinsulinemia initially. As previously seen in a cross-sectional study, the 3-hour glucose storage measured by continuous indirect calorimetry remained unaltered in patients with IGT, whereas it decreased in NIDDM patients. A further decrease in glucose storage was observed with the lowering of the insulin response in the previously hyperinsulinemic diabetics. These results confirm cross-sectional studies that suggest successive phases in the evolution of obesity to diabetes: A, NGT; B, IGT (the hyperglycemia normalizing the glucose storage over 3 hours); C, diabetes with increased insulin response, where hyperglycemia does not correct the resistance to glucose storage anymore; and D, diabetes with low insulin response, with a low glucose storage and an elevated fasting and postload glycemia.
Similar articles
- Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
Motala AA, Omar MA, Gouws E. Motala AA, et al. Diabetes Care. 1997 Jul;20(7):1101-7. doi: 10.2337/diacare.20.7.1101. Diabetes Care. 1997. PMID: 9203444 - Metabolic defects in persistent impaired glucose tolerance are related to the family history of non-insulin-dependent diabetes mellitus.
Niskanen L, Sarlund H, Laakso M. Niskanen L, et al. Metabolism. 1995 Aug;44(8):1099-104. doi: 10.1016/0026-0495(95)90109-4. Metabolism. 1995. PMID: 7637652 - Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C, Miccoli R, Trombetta M, Giorgino F, Frontoni S, Faloia E, Marchesini G, Dolci MA, Cavalot F, Cavallo G, Leonetti F, Bonadonna RC, Del Prato S; GENFIEV Investigators. Bianchi C, et al. J Clin Endocrinol Metab. 2013 May;98(5):2100-5. doi: 10.1210/jc.2012-3971. Epub 2013 Mar 28. J Clin Endocrinol Metab. 2013. PMID: 23539736 Clinical Trial. - Energy and substrate metabolism in obesity and postobese state.
Tappy L, Felber JP, Jéquier E. Tappy L, et al. Diabetes Care. 1991 Dec;14(12):1180-8. doi: 10.2337/diacare.14.12.1180. Diabetes Care. 1991. PMID: 1773703 Review.
Cited by
- Association of Multiple Urinary Phthalates Metabolites with Diabetes Risk in Elderly Population.
Wang Y, Chen J, Shi J, Zhao Z, Chen J, Deng Y, Wang T, Wang Y, Xiang Y, He M. Wang Y, et al. Environ Health (Wash). 2023 Nov 10;2(3):140-149. doi: 10.1021/envhealth.3c00120. eCollection 2024 Mar 15. Environ Health (Wash). 2023. PMID: 39473819 Free PMC article. - Correlation of Leptin in Patients With Type 2 Diabetes Mellitus.
Manglani K, Anika NN, Patel D, Jhaveri S, Avanthika C, Sudan S, Alimohamed Z, Tiwari K. Manglani K, et al. Cureus. 2024 Apr 5;16(4):e57667. doi: 10.7759/cureus.57667. eCollection 2024 Apr. Cureus. 2024. PMID: 38707092 Free PMC article. Review. - The Role of Selenium Nanoparticles in Addressing Diabetic Complications: A Comprehensive Study.
Satpathy S, Panigrahi LL, Arakha M. Satpathy S, et al. Curr Top Med Chem. 2024;24(15):1327-1342. doi: 10.2174/0115680266299494240326083936. Curr Top Med Chem. 2024. PMID: 38561614 Review. - Sodium Glucose Transporter-2 Inhibitors (SGLT2Is)-TLRs Axis Modulates Diabetes.
Niknejad A, Hosseini Y, Shamsnia HS, Kashani AS, Rostamian F, Momtaz S, Abdolghaffari AH. Niknejad A, et al. Cell Biochem Biophys. 2023 Dec;81(4):599-613. doi: 10.1007/s12013-023-01164-x. Epub 2023 Sep 1. Cell Biochem Biophys. 2023. PMID: 37658280 Review. - Patterns of Non-Communicable Disease, Multimorbidity, and Population Awareness in Bahir Dar, Northwest Ethiopia: A Cross-Sectional Study.
Alamnia TT, Sargent GM, Kelly M. Alamnia TT, et al. Int J Gen Med. 2023 Jul 13;16:3013-3031. doi: 10.2147/IJGM.S421749. eCollection 2023. Int J Gen Med. 2023. PMID: 37465551 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials